{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:25:56Z","timestamp":1789698356168,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Atomic Energy Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Copper-64 (\n                    <jats:sup>64<\/jats:sup>\n                    Cu) and Copper-67 (\n                    <jats:sup>67<\/jats:sup>\n                    Cu) are promising theranostic isotopes for PET imaging and targeted radiotherapy. In this study, 2,2\u2019-(1,2,4-Oxadiazole-3,5-diyl)di aniline (ODDA) was successfully radiolabeled with\n                    <jats:sup>64+67<\/jats:sup>\n                    Cu, achieving high radiolabeling yield (97.0\u2009\u00b1\u20090.8%) and excellent stability in serum over five days. The optimized radiolabeling conditions included a ligand concentration of 30\u00a0\u00b5g, pH 4, a reaction time of 15\u00a0min, and a temperature of 60\u00a0\u00b0C. The biodistribution study in Ehrlich ascites carcinoma-bearing mice showed an initial tumor uptake of 7.8\u2009\u00b1\u20090.4%ID\/g at 0.5\u00a0h, peaking at 18.0\u2009\u00b1\u20090.3ID\/g at 2\u00a0h, confirming selective tumor accumulation. The log P value of -0.8 indicated a hydrophilic nature, leading to predominant renal clearance. Molecular docking studies showed strong binding to EGFR (-9.1\u00a0kcal\/mol) and VEGFR2 (-8.6\u00a0kcal\/mol), suggesting potential anticancer activity.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-21804-x","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:17:55Z","timestamp":1761556675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiolabeling and evaluation of 64+67Cu-2,2\u2019-(1,2,4-Oxadiazole-3,5-diyl)di aniline as a theranostic agent for solid tumors"],"prefix":"10.1038","volume":"15","author":[{"given":"Mohamed A.","family":"Gizawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Salah","family":"Ayoup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad S.","family":"Kodous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Taha","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Motaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"21804_CR1","unstructured":"Radioisotopes, I. A. E. A., and Radiopharmaceuticals Series No. \"7. (2022) Copper-64 Radiopharmaceuticals: Production, Quality Control and Clinical Applications."},{"issue":"4","key":"21804_CR2","first-page":"379","volume":"24","author":"CJ Anderson","year":"2009","unstructured":"Anderson, C. J. & Ferdani, R. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother. Radiopharm. 24(4), 379\u2013393 (2009).","journal-title":"Cancer Biother. Radiopharm."},{"key":"21804_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00259-001-0724-y","volume":"29","author":"I Novak-Hofer","year":"2002","unstructured":"Novak-Hofer, I. & Schubiger, A. P. Copper-67 as a therapeutic nuclide for radioimmunotherapy. Eur. J. Nucl. Med. Mol. Imaging 29, 821\u2013830 (2002).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"21804_CR4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/molecules27051501","volume":"27","author":"L Mou","year":"2022","unstructured":"Mou, L. et al. 67Cu production capabilities: A mini review. Molecules 27(5), 1501 (2022).","journal-title":"Molecules"},{"issue":"11","key":"21804_CR5","doi-asserted-by":"publisher","first-page":"9154","DOI":"10.3390\/ijms24119154","volume":"24","author":"OO Krasnovskaya","year":"2023","unstructured":"Krasnovskaya, O. O. et al. Recent advances in 64Cu\/67Cu-based radiopharmaceuticals. Int. J. Mol. Sci. 24(11), 9154 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"21804_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00775-015-1318-7","volume":"21","author":"N Wu","year":"2016","unstructured":"Wu, N. et al. Promising bifunctional chelators for copper 64-PET imaging: Practical 64 Cu radiolabeling and high in vitro and in vivo complex stability. JBIC J. Biol. Inorgan. Chemistry 21, 177\u2013184 (2016).","journal-title":"JBIC J. Biol. Inorgan. Chemistry"},{"issue":"5","key":"21804_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2174\/157340611796799177","volume":"7","author":"M Shokeen","year":"2011","unstructured":"Shokeen, M. & Wadas, J. T. The development of copper radiopharmaceuticals for imaging and therapy. Med. Chem. 7(5), 413\u2013429 (2011).","journal-title":"Med. Chem."},{"issue":"9","key":"21804_CR8","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s00253-022-11969-0","volume":"106","author":"UA Atmaram","year":"2022","unstructured":"Atmaram, U. A. & Roopan, S. M. Biological activity of oxadiazole and thiadiazole derivatives. Appl. Microbiol. Biotechnol. 106(9), 3489\u20133505 (2022).","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"5","key":"21804_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/jm2013248","volume":"55","author":"J Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m, J., Hogner, A., Llin\u00e0s, A., Wellner, E. & Plowright, A. T. Oxadiazoles in medicinal chemistry. J. Med. Chem. 55(5), 1817\u20131830 (2012).","journal-title":"J. Med. Chem."},{"issue":"11","key":"21804_CR10","first-page":"2405","volume":"29","author":"FS Cunha","year":"2018","unstructured":"Cunha, F. S., Nogueira, J. M. & Aguiar, A. P. D. Synthesis and antibacterial evaluation of 3, 5-diaryl-1, 2, 4-oxadiazole derivatives. J. Braz. Chem. Soc. 29(11), 2405\u20132416 (2018).","journal-title":"J. Braz. Chem. Soc."},{"issue":"6","key":"21804_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/cbdd.14100","volume":"100","author":"D Tiwari","year":"2022","unstructured":"Tiwari, D. et al. 1, 3, 4-oxadiazole derivatives as potential antimicrobial agents. Chem. Biol. Drug Des. 100(6), 1086\u20131121 (2022).","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"21804_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/1389557514666140329200745","volume":"14","author":"O Bora","year":"2014","unstructured":"Bora, O. et al. [1, 2, 4]-Oxadiazoles: Synthesis and biological applications. Mini Rev. Med. Chem. 14(4), 355\u2013369 (2014).","journal-title":"Mini Rev. Med. Chem."},{"key":"21804_CR13","doi-asserted-by":"publisher","first-page":"103754","DOI":"10.1016\/j.bioorg.2020.103754","volume":"98","author":"F Shamsi","year":"2020","unstructured":"Shamsi, F. et al. Synthesis and SAR studies of novel 1, 2, 4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy. Bioorgan. Chem. 98, 103754 (2020).","journal-title":"Bioorgan. Chem."},{"key":"21804_CR14","doi-asserted-by":"publisher","first-page":"103828","DOI":"10.1016\/j.bioorg.2020.103828","volume":"99","author":"KB Loboda","year":"2020","unstructured":"Loboda, K. B. et al. Design and synthesis of 3, 5-substituted 1, 2, 4-oxadiazoles as catalytic inhibitors of human DNA topoisomerase II\u03b1. Bioorgan. Chem. 99, 103828 (2020).","journal-title":"Bioorgan. Chem."},{"key":"21804_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bioorg.2019.01.067","volume":"86","author":"MR Mohammed","year":"2019","unstructured":"Mohammed, M. R. Design, synthesis, and cytotoxicity screening of 5-aryl-3-(2-(pyrrolyl) thiophenyl)-1, 2, 4-oxadiazoles as potential antitumor molecules on breast cancer MCF-7 cells. Bioorg. Chem. 86, 609\u2013623 (2019).","journal-title":"Bioorg. Chem."},{"key":"21804_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejmech.2019.01.001","volume":"165","author":"W Caneschi","year":"2019","unstructured":"Caneschi, W. et al. Synthesis and anticancer evaluation of new lipophilic 1, 2, 4 and 1, 3, 4-oxadiazoles. Eur. J. Med. Chem. 165, 18\u201330 (2019).","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"21804_CR17","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1021\/acs.jmedchem.6b01609","volume":"60","author":"S Moniot","year":"2017","unstructured":"Moniot, S. et al. Development of 1, 2, 4-oxadiazoles as potent and selective inhibitors of the human deacetylase sirtuin 2: Structure\u2013activity relationship, X-ray crystal structure, and anticancer activity. J. Med. Chem. 60(6), 2344\u20132360 (2017).","journal-title":"J. Med. Chem."},{"key":"21804_CR18","doi-asserted-by":"publisher","first-page":"104439","DOI":"10.1016\/j.bioorg.2020.104439","volume":"105","author":"MF Mohamed","year":"2020","unstructured":"Mohamed, M. F. et al. Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1, 2, 4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS\/PGE2 inhibitors. Bioorgan. Chem. 105, 104439 (2020).","journal-title":"Bioorgan. Chem."},{"key":"21804_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bioorg.2019.02.043","volume":"85","author":"BG Youssif","year":"2019","unstructured":"Youssif, B. G. et al. Novel aryl carboximidamide and 3-aryl-1, 2, 4-oxadiazole analogues of naproxen as dual selective COX-2\/15-LOX inhibitors: Design, synthesis and docking studies. Bioorg. Chem. 85, 577\u2013584 (2019).","journal-title":"Bioorg. Chem."},{"key":"21804_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molstruc.2018.01.060","volume":"1159","author":"S Yatam","year":"2018","unstructured":"Yatam, S. et al. Focused library design and synthesis of 2-mercapto benzothiazole linked 1, 2, 4-oxadiazoles as COX-2\/5-LOX inhibitors. J. Mol. Struct. 1159, 193\u2013204 (2018).","journal-title":"J. Mol. Struct."},{"issue":"18","key":"21804_CR21","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2174\/1389557518666180524112050","volume":"18","author":"G Chawla","year":"2018","unstructured":"Chawla, G. 1, 2, 4-Oxadiazole as a privileged scaffold for anti-inflammatory and analgesic activities: A review. Mini. Rev. Med. Chem. 18(18), 1536\u20131547 (2018).","journal-title":"Mini. Rev. Med. Chem."},{"key":"21804_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112874","volume":"209","author":"M Wang","year":"2021","unstructured":"Wang, M. et al. Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1, 2, 4-oxadiazole derivatives as novel GSK-3\u03b2 inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents. Eur. J. Med. Chem. 209, 112874 (2021).","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"21804_CR23","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1080\/00397911.2016.1244692","volume":"46","author":"J Brahmi","year":"2016","unstructured":"Brahmi, J. et al. Unprecedented stereoselective synthesis of 3-methylisoxazolidine-5-aryl-1, 2, 4-oxadiazoles via 1, 3-dipolar cycloaddition and study of their in vitro antioxidant activity. Synth. Commun. 46(24), 2037\u20132044 (2016).","journal-title":"Synth. Commun."},{"issue":"5","key":"21804_CR24","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s11030-021-10375-4","volume":"26","author":"TM Dhameliya","year":"2022","unstructured":"Dhameliya, T. M., Chudasma, S. J., Patel, T. M. & Dave, B. P. A review on synthetic account of 1, 2, 4-oxadiazoles as anti-infective agents. Mol. Diversity 26(5), 2967\u20132980 (2022).","journal-title":"Mol. Diversity"},{"key":"21804_CR25","doi-asserted-by":"crossref","unstructured":"Brogowska, K.K., Zajkowska, M., & Mroczko, B. (2023) Vascular endothelial growth factor ligands and receptors in breast cancer. J. Clin. Med. 12","DOI":"10.3390\/jcm12062412"},{"key":"21804_CR26","doi-asserted-by":"crossref","unstructured":"Shaaban, N.Z., Ibrahim N.K., Saada H.N., et al (2022) The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients. Oncol. Res. 30","DOI":"10.32604\/or.2022.027277"},{"key":"21804_CR27","doi-asserted-by":"crossref","unstructured":"Hagag, S., Kodous, A., & Shaaban, H.A. (2023). Molecular and immunohistochemical alterations in breast cancer patients in upper Egypt. 11","DOI":"10.52547\/rbmb.11.4.532"},{"key":"21804_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jrras.2022.08.001","volume":"15","author":"NZ Shaban","year":"2022","unstructured":"Shaban, N. Z. et al. miR-34a and miR-21 as biomarkers in evaluating the response of chemo-radiotherapy in Egyptian breast cancer patients. J. Radiat. Res. Appl. Sci. 15, 285\u2013292. https:\/\/doi.org\/10.1016\/j.jrras.2022.08.001 (2022).","journal-title":"J. Radiat. Res. Appl. Sci."},{"issue":"3","key":"21804_CR29","first-page":"96","volume":"9","author":"K Sabitha","year":"2016","unstructured":"Sabitha, K., Kodous, A. & Rajkumar, T. Computational analysis of mutations in really interesting new gene finger domain and BRCA1 c terminus domain of breast cancer susceptibility gene. Asian J. Pharm. Clin. Res 9(3), 96\u2013102 (2016).","journal-title":"Asian J. Pharm. Clin. Res"},{"issue":"6","key":"21804_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1515\/oncologie-2023-0244","volume":"25","author":"AS Kodous","year":"2023","unstructured":"Kodous, A. S., Balaiah, M. & Ramanathan, P. Single cell RNA sequencing\u2013a valuable tool for cancer immunotherapy: A mini review. Oncologie 25(6), 635\u2013639 (2023).","journal-title":"Oncologie"},{"key":"21804_CR31","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-14-0037","author":"T Ohba","year":"2014","unstructured":"Ohba, T. et al. Autocrine VEGF\/VEGFR1 signaling in a subpopulation of cells associates with aggressive osteosarcoma. Mol. Cancer Res. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0037 (2014).","journal-title":"Mol. Cancer Res."},{"key":"21804_CR32","doi-asserted-by":"publisher","first-page":"116274","DOI":"10.1016\/j.biopha.2024.116274","volume":"172","author":"OA AboZaid","year":"2024","unstructured":"AboZaid, O. A. et al. Targeting the NF-\u03baB p65\/Bcl-2 signaling pathway in hepatic cellular carcinoma using radiation assisted synthesis of zinc nanoparticles coated with naturally isolated gallic acid. Biomed. Pharmacother. 172, 116274 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"21804_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2011.03.012","volume":"131","author":"AK Larsen","year":"2011","unstructured":"Larsen, A. K. et al. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol. Ther. 131, 80 (2011).","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"21804_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.7142","volume":"37","author":"MS Ayoup","year":"2023","unstructured":"Ayoup, M. S. et al. Syntheses, characterizations, and Hirshfeld analysis of Ag (I) and Cu (II) complexes: A novel potent Ag (I)-based oxadiazole anticancer agent. Appl. Organomet. Chem. 37(8), e7142 (2023).","journal-title":"Appl. Organomet. Chem."},{"key":"21804_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.108769","volume":"191","author":"MA Gizawy","year":"2023","unstructured":"Gizawy, M. A., Abdelmonem, I. M., Elsharma, E. M. & Emara, A. M. Separation of 64+67Cu (II) from irradiated natural zinc target by sodium alginate-polyacrylic acid\/nanohalloysite composite. Microchem. J. 191, 108769 (2023).","journal-title":"Microchem. J."},{"key":"21804_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10967-012-1885-9","volume":"295","author":"Y Fazaeli","year":"2013","unstructured":"Fazaeli, Y. et al. Preparation, nano purification, quality control and labeling optimization of [64 Cu]-5, 10, 15, 20-tetrakis (penta fluoro phenyl) porphyrin complex as a possible imaging agent. J. Radioanal. Nucl. Chem. 295, 255\u2013263 (2013).","journal-title":"J. Radioanal. Nucl. Chem."},{"issue":"1","key":"21804_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41181-022-00171-2","volume":"7","author":"N AlHokbany","year":"2022","unstructured":"AlHokbany, N. et al. Development of new copper-64 labeled rhodamine: A potential PET myocardial perfusion imaging agent. EJNMMI Radiopharm. Chem. 7(1), 19 (2022).","journal-title":"EJNMMI Radiopharm. Chem."},{"issue":"11","key":"21804_CR38","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1515\/ract-2023-0175","volume":"112","author":"MA Gizawy","year":"2024","unstructured":"Gizawy, M. A., Shamsel-Din, H. A., El-Tahawy, M. M. & Ibrahim, A. A. Synthesis, in silico and biodistribution studies of a novel 47Sc-radiolabeled \u03b1-amino acid ester derivative attached to pyrazine and tetrazole rings for tumor targeted radiotherapy. Radiochim. Acta 112(11), 869\u2013882 (2024).","journal-title":"Radiochim. Acta"},{"issue":"8","key":"21804_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jlcr.3841","volume":"63","author":"HA Shamsel-Din","year":"2020","unstructured":"Shamsel-Din, H. A., Gizawy, M. A., Zaki, E. G. & Elgendy, A. A novel 99mTc-diester complex as tumor targeting agent: Synthesis, radiolabeling, and biological distribution study. J. Labelled Compd. Radiopharm. 63(8), 376\u2013385 (2020).","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"21804_CR40","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10967-020-07385-1","volume":"326","author":"HA Shamsel-Din","year":"2020","unstructured":"Shamsel-Din, H. A., Gizawy, M. A. & Abdelaziz, G. Molecular docking and preliminary bioevaluation of 99mTc-Thiadiazuron as a novel potential agent for cervical cancer imaging. J. Radioanal. Nucl. Chem. 326, 1375\u20131381 (2020).","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"21804_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21256","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. https:\/\/doi.org\/10.1002\/jcc.21256 (2009).","journal-title":"J. Comput. Chem."},{"key":"21804_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.4525","author":"EM Zayed","year":"2019","unstructured":"Zayed, E. M., Hindy, A. M. M. & Mohamed, G. G. Coordination behaviour, molecular docking, density functional theory calculations and biological activity studies of some transition metal complexes of bis-Schiff base ligand. Appl. Organomet. Chem. https:\/\/doi.org\/10.1002\/aoc.4525 (2019).","journal-title":"Appl. Organomet. Chem."},{"issue":"13","key":"21804_CR43","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1016\/j.bmc.2011.05.010","volume":"19","author":"WM Rockey","year":"2011","unstructured":"Rockey, W. M. et al. Synthesis and radiolabeling of chelator\u2013RNA aptamer bioconjugates with copper-64 for targeted molecular imaging. Bioorg. Med. Chem. 19(13), 4080\u20134090 (2011).","journal-title":"Bioorg. Med. Chem."},{"key":"21804_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-018-4291-6","volume":"20","author":"X Xu","year":"2018","unstructured":"Xu, X., Li, Y., Cao, T., Cheng, J. & Zhang, Y. A novel, chelator-free method for 64 Cu labeling of dendrimers. J. Nanopart. Res. 20, 1\u201311 (2018).","journal-title":"J. Nanopart. Res."},{"issue":"10","key":"21804_CR45","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4155\/fmc-2023-0342","volume":"16","author":"AM Soliman","year":"2024","unstructured":"Soliman, A. M., Kodous, A. S., Al-Sherif, D. A. & Ghorab, M. M. Quinazoline sulfonamide derivatives targeting MicroRNA-34a\/MDM4\/p53 apoptotic axis with radiosensitizing activity. Future Med. Chem. 16(10), 929\u2013948 (2024).","journal-title":"Future Med. Chem."},{"key":"21804_CR46","doi-asserted-by":"crossref","unstructured":"Khalil, S. A., Awadallah-F, A., Khaffaga, M. R., Fathy, R. M., & Kodous, A. S. (2024). Gamma radiation assisted green synthesis of silver nanoparticles-loaded (polyacrylamide\/chitosan) hydrogel nanocomposites and their using as antifungal against candida Albicans and anti-cancer modulator.","DOI":"10.21203\/rs.3.rs-4686117\/v1"},{"key":"21804_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.procbio.2025.03.009","volume":"153","author":"AS Kodous","year":"2025","unstructured":"Kodous, A. S., Fathy, R. M., Mazhar, A., Shafaa, M. W. & Shalaby, M. S. Green synthesis of \u03b2-carotene-loaded liposome as antibacterial, antibiofilm and anti-inflammatory modulator: Targeting no\/inos\/nf-\u03ba b signaling pathway in mcf-7 cancer cell line. Process Biochem. 153, 135\u2013153 (2025).","journal-title":"Process Biochem."},{"key":"21804_CR48","unstructured":"Thorough examination of the potential biological implications of the cuproptosis-related gene LIPT2 in the prognosis and immunotherapy in pan-cancer"},{"key":"21804_CR49","unstructured":"Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance"},{"issue":"3","key":"21804_CR50","doi-asserted-by":"publisher","first-page":"738","DOI":"10.62347\/YORR3755","volume":"16","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses. Am. J. Transl. Res. 16(3), 738 (2024).","journal-title":"Am. J. Transl. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21804-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:03:36Z","timestamp":1761948216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21804"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21804-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37342"}}